Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Basolateral cell membrane Multi-pass membrane protein Note=Associates with CLDN1 and the CLDN1-CD81 complex localizes to the basolateral cell membrane. |
Domain |
PF00335 Tetraspanin family |
Function |
May play an important role in the regulation of lymphoma cell growth. Interacts with a 16-kDa Leu-13 protein to form a complex possibly involved in signal transduction. May act as the viral receptor for HCV.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes. Associates with CLDN1 and the CLDN1-CD81 receptor complex is essential for HCV entry into host cell. |
Biological Process |
GO:0000187 activation of MAPK activity GO:0002694 regulation of leukocyte activation GO:0002696 positive regulation of leukocyte activation GO:0006644 phospholipid metabolic process GO:0006898 receptor-mediated endocytosis GO:0007039 protein catabolic process in the vacuole GO:0009894 regulation of catabolic process GO:0009896 positive regulation of catabolic process GO:0018108 peptidyl-tyrosine phosphorylation GO:0018212 peptidyl-tyrosine modification GO:0019058 viral life cycle GO:0019062 virion attachment to host cell GO:0019216 regulation of lipid metabolic process GO:0030260 entry into host cell GO:0030888 regulation of B cell proliferation GO:0030890 positive regulation of B cell proliferation GO:0031329 regulation of cellular catabolic process GO:0031331 positive regulation of cellular catabolic process GO:0031623 receptor internalization GO:0031647 regulation of protein stability GO:0032147 activation of protein kinase activity GO:0032943 mononuclear cell proliferation GO:0032944 regulation of mononuclear cell proliferation GO:0032946 positive regulation of mononuclear cell proliferation GO:0033674 positive regulation of kinase activity GO:0042100 B cell proliferation GO:0042113 B cell activation GO:0042176 regulation of protein catabolic process GO:0043112 receptor metabolic process GO:0043126 regulation of 1-phosphatidylinositol 4-kinase activity GO:0043128 positive regulation of 1-phosphatidylinositol 4-kinase activity GO:0043405 regulation of MAP kinase activity GO:0043406 positive regulation of MAP kinase activity GO:0043410 positive regulation of MAPK cascade GO:0043550 regulation of lipid kinase activity GO:0044406 adhesion of symbiont to host GO:0044409 entry into host GO:0044650 adhesion of symbiont to host cell GO:0045732 positive regulation of protein catabolic process GO:0045834 positive regulation of lipid metabolic process GO:0045860 positive regulation of protein kinase activity GO:0046651 lymphocyte proliferation GO:0046718 viral entry into host cell GO:0046813 receptor-mediated virion attachment to host cell GO:0050670 regulation of lymphocyte proliferation GO:0050671 positive regulation of lymphocyte proliferation GO:0050730 regulation of peptidyl-tyrosine phosphorylation GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation GO:0050864 regulation of B cell activation GO:0050865 regulation of cell activation GO:0050867 positive regulation of cell activation GO:0050871 positive regulation of B cell activation GO:0051249 regulation of lymphocyte activation GO:0051251 positive regulation of lymphocyte activation GO:0051701 interaction with host GO:0051806 entry into cell of other organism involved in symbiotic interaction GO:0051828 entry into other organism involved in symbiotic interaction GO:0055094 response to lipoprotein particle GO:0055098 response to low-density lipoprotein particle GO:0061462 protein localization to lysosome GO:0070661 leukocyte proliferation GO:0070663 regulation of leukocyte proliferation GO:0070665 positive regulation of leukocyte proliferation GO:0071402 cellular response to lipoprotein particle stimulus GO:0071404 cellular response to low-density lipoprotein particle stimulus GO:0071900 regulation of protein serine/threonine kinase activity GO:0071902 positive regulation of protein serine/threonine kinase activity GO:0072665 protein localization to vacuole GO:0090218 positive regulation of lipid kinase activity GO:1903362 regulation of cellular protein catabolic process GO:1903364 positive regulation of cellular protein catabolic process GO:1903725 regulation of phospholipid metabolic process GO:1903727 positive regulation of phospholipid metabolic process GO:1904350 regulation of protein catabolic process in the vacuole GO:1904352 positive regulation of protein catabolic process in the vacuole |
Molecular Function |
GO:0003823 antigen binding GO:0023023 MHC protein complex binding GO:0023026 MHC class II protein complex binding GO:1990459 transferrin receptor binding |
Cellular Component |
GO:0001772 immunological synapse GO:0005924 cell-substrate adherens junction GO:0005925 focal adhesion GO:0030055 cell-substrate junction |
KEGG |
hsa04662 B cell receptor signaling pathway |
Reactome |
R-HSA-1280218: Adaptive Immune System R-HSA-168256: Immune System R-HSA-198933: Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between CD81 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between CD81 and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of CD81 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of CD81 in various data sets.
|
There is no record. |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of CD81. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of CD81. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by CD81. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of CD81. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of CD81 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between CD81 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | CD81 |
Name | CD81 molecule |
Aliases | TAPA-1; TSPAN28; TAPA1; CD81 antigen (target of antiproliferative antibody 1); CVID6; S5.7; 26 kDa cell surf ...... |
Chromosomal Location | 11p15.5 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting CD81 collected from DrugBank database. |
There is no record. |